Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial | Zendy

Rocío Montejano | Zendy; Fernando Calle | Zendy; María Velasco | Zendy; Carlos Guijarro | Zendy; Javier QueirugaParada | Zendy; María Jiménez-González | Zendy; Patricia GonzálezRuano | Zendy; Patricia Martínez | Zendy; Ane Josune Goikoetxea | Zendy; Marta Ibarrola | Zendy; Marianela Ciudad | Zendy; Ángela Gutiérrez | Zendy; Miguel Torralba | Zendy; Ana Díaz-Brasero | Zendy; Pablo Ryan | Zendy; Cristina Marcelo | Zendy; Cristina Díez | Zendy; Sofía Ibarra | Zendy; Esperanza Merino | Zendy; Vicente Estrada | Zendy; Javier Marcos | Zendy; Maria Teresa Novella | Zendy; Maria Alba Rivera | Zendy; Manuel Ruiz Muñoz | Zendy; Marta de Miguel | Zendy; Llanos Soler | Zendy; Mikel del Álamo | Zendy; Santiago Moreno | Zendy; Antonio J. Carcas | Zendy; Alberto M. Borobia | Zendy; José Ramón Arribas | Zendy

Open Access

Tenofovir Disoproxil Fumarate/Emtricitabine and Baricitinib for Patients at High Risk of Severe Coronavirus Disease 2019: The PANCOVID Randomized Clinical Trial

Author(s) -

Rocío Montejano,

Fernando Calle,

María Velasco,

Carlos Guijarro,

Javier QueirugaParada,

María Jiménez-González,

Patricia GonzálezRuano,

Patricia Martínez,

Ane Josune Goikoetxea,

Marta Ibarrola,

Marianela Ciudad,

Ángela Gutiérrez,

Miguel Torralba,

Ana Díaz-Brasero,

Pablo Ryan,

Cristina Marcelo,

Cristina Díez,

Sofía Ibarra,

Esperanza Merino,

Vicente Estrada,

Javier Marcos,

Maria Teresa Novella,

Maria Alba Rivera,

Manuel Ruiz Muñoz,

Marta de Miguel,

Llanos Soler,

Mikel del Álamo,

Santiago Moreno,

Antonio J. Carcas,

Alberto M. Borobia,

José Ramón Arribas

Publication year - 2022

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1093/cid/ciac628

Subject(s) - medicine , clinical endpoint , emtricitabine , relative risk , randomization , randomized controlled trial , confidence interval , viral load , immunology , human immunodeficiency virus (hiv) , antiretroviral therapy

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research